Related references
Note: Only part of the references are listed.Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis
Maurizio Cutolo et al.
AUTOIMMUNITY REVIEWS (2013)
The Effects of TNF α Antagonist Therapy on Bone Metabolism in Rheumatoid Arthritis: A Systematic Review
Rajalingham Sakthiswary et al.
CURRENT DRUG TARGETS (2013)
A study of the link between bone turnover markers and bone mineral density with inflammation and body mass in postmenopausal women with active rheumatoid arthritis
Anna Straburzynska-Lupa et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2013)
Periarticular Bone Gain at Proximal Interphalangeal Joints and Changes in Bone Turnover Markers in Response to Tumor Necrosis Factor Inhibitors in Rheumatoid and Psoriatic Arthritis
Agnes Szentpetery et al.
JOURNAL OF RHEUMATOLOGY (2013)
Hunting for the pathogenesis of rheumatoid arthritis: core-needle biopsy of inguinal lymph nodes as a new research tool
Maria J. H. de Hair et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Receptor Activator of Nuclear Factor κB Ligand (RANKL) Protein Expression by B Lymphocytes Contributes to Ovariectomy-induced Bone Loss
Melda Onal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Osteoprotegerin expression in bone marrow by treatment with tocilizumab in rheumatoid arthritis
Katsuaki Kanbe et al.
RHEUMATOLOGY INTERNATIONAL (2012)
IL-6 Receptor Inhibition Positively Modulates Bone Balance in Rheumatoid Arthritis Patients with an Inadequate Response to Anti-Tumor Necrosis Factor Therapy: Biochemical Marker Analysis of Bone Metabolism in the Tocilizumab RADIATE Study (NCT00106522)
Morten A. Karsdal et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2012)
Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study
Jun Hashimoto et al.
MODERN RHEUMATOLOGY (2011)
Influence of Rituximab on markers of bone remodeling in patients with rheumatoid arthritis: a prospective open-label pilot study
Gert Hein et al.
RHEUMATOLOGY INTERNATIONAL (2011)
Inhibition of antigen presentation and T cell costimulation blocks PTH-induced bone loss
Brahmchetna Bedi et al.
SKELETAL BIOLOGY AND MEDICINE (2010)
Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates
Robin K. Dore et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis
Lilian H. D. van Tuyl et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression
Gisela Ruiz Heiland et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Rapid and Sustained Improvement in Bone and Cartilage Turnover Markers With the Anti-Interleukin-6 Receptor Inhibitor Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate Results From a Substudy of the Multicenter Double-Blind, Placebo-Controlled Trial of Tocilizumab in Inadequate Responders to Methotrexate Alone
Patrick Garnero et al.
ARTHRITIS AND RHEUMATISM (2010)
Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis
M. Gueler-Yueksel et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Inhibition of Interleukin-6 Receptor Directly Blocks Osteoclast Formation In Vitro and In Vivo
Roland Axmann et al.
ARTHRITIS AND RHEUMATISM (2009)
Costimulation blockade in rheumatic diseases: where we are?
Vincent Goeb et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
Effect of Tumor Necrosis Factor Alpha Inhibition on Bone Density and Turnover Markers in Patients with Rheumatoid Arthritis and Spondyloarthropathy
Cheryl Barnabe et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
CTLA-4 directly inhibits osteoclast formation
R. Axmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Circulating Dickkopf-1 and Radiological Progression in Patients with Early Rheumatoid Arthritis Treated with Etanercept
Patrick Garnero et al.
JOURNAL OF RHEUMATOLOGY (2008)
IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-α and IL-17
M. Hashizume et al.
RHEUMATOLOGY (2008)
Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis
F. Chopin et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Baseline serum RANKL levels may serve to predict remission in rheumatoid arthritis patients treated with TNF antagonists
Isidoro Gonzalez-Alvaro et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab
Hubert Marotte et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis
M. Vis et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis
PKK Wong et al.
ARTHRITIS AND RHEUMATISM (2006)
Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis
AI Catrina et al.
ARTHRITIS AND RHEUMATISM (2006)
Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-α antibody:: a prospective open-label pilot study
U Lange et al.
RHEUMATOLOGY (2005)
Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment
K Briot et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
RANK, RANKL and osteoprotegerin in arthritic bone loss
MC Bezerra et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2005)
Comparison of dual X-ray absorptiometry (DXA), digital X-ray radiogrammetry (DXR), and conventional radiographs in the evaluation of osteoporosis and bone erosions in patients with rheumatoid arthritis
T Jensen et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2005)
Hand cortical bone mass and its associations with radiographic joint damage and fractures in 50-70 year old female patients with rheumatoid arthritis: cross sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study
G Haugeberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Predicting erosive disease in rheumatoid arthritis. A longitudinal study of changes in bone density using digital X-ray radiogrammetry: a pilot study
A Stewart et al.
RHEUMATOLOGY (2004)
Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkers
P Garnero et al.
CURRENT OPINION IN RHEUMATOLOGY (2004)
Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis
HF d'Elia et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: The Oslo-Truro-Amsterdam (OSTRA) Collaborative Study
MC Lodder et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
Bone destruction in arthritis
EM Gravallese
ANNALS OF THE RHEUMATIC DISEASES (2002)
Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis -: The COBRA Study
P Garnero et al.
ARTHRITIS AND RHEUMATISM (2002)
Bone changes in early rheumatoid arthritis
MJ Green et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2001)
Share Paper
